18th May 2021 12:14
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 17 May 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
1,659,782 | 1.29% | 172,205 | 0.13% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
72,359 | 0.06% | 0 | 0.00% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 6,100 | 0.00% | 6,100 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
1,738,241 | 1.35% | 178,305 | 0.14% | ||
|
|
|
| ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 1 | 265.5400 USD |
Purchase | 1 | 265.1700 USD |
Purchase | 3 | 264.8500 USD |
Purchase | 4 | 265.9700 USD |
Purchase | 16 | 265.8600 USD |
Purchase | 45 | 264.6404 USD |
Purchase | 77 | 265.0900 USD |
Purchase | 87 | 265.0800 USD |
Purchase | 110 | 266.0722 USD |
Purchase | 255 | 264.3900 USD |
Purchase | 310 | 265.8340 USD |
Purchase | 600 | 265.9341 USD |
Purchase | 1,300 | 265.8131 USD |
Purchase | 2,395 | 266.0000 USD |
Purchase | 2,468 | 265.6259 USD |
Purchase | 3,411 | 265.9574 USD |
Purchase | 7,240 | 265.5233 USD |
Purchase | 21,948 | 265.7986 USD |
Purchase | 141,339 | 265.8244 USD |
Sale | 2 | 265.5400 USD |
Sale | 8 | 266.2000 USD |
Sale | 8 | 266.0700 USD |
Sale | 8 | 266.1800 USD |
Sale | 20 | 265.8820 USD |
Sale | 22 | 265.9209 USD |
Sale | 24 | 266.1700 USD |
Sale | 40 | 266.0500 USD |
Sale | 100 | 265.3700 USD |
Sale | 100 | 265.8700 USD |
Sale | 151 | 266.1961 USD |
Sale | 200 | 265.7300 USD |
Sale | 235 | 265.7396 USD |
Sale | 249 | 266.2220 USD |
Sale | 255 | 264.3900 USD |
Sale | 300 | 266.0833 USD |
Sale | 300 | 265.7850 USD |
Sale | 337 | 266.3002 USD |
Sale | 394 | 265.0424 USD |
Sale | 455 | 265.5546 USD |
Sale | 500 | 265.8350 USD |
Sale | 550 | 266.0600 USD |
Sale | 932 | 265.7825 USD |
Sale | 1,300 | 265.8131 USD |
Sale | 1,400 | 265.5300 USD |
Sale | 1,436 | 266.0863 USD |
Sale | 1,522 | 265.9994 USD |
Sale | 1,535 | 265.5308 USD |
Sale | 1,555 | 265.5679 USD |
Sale | 1,646 | 266.0000 USD |
Sale | 1,721 | 265.6936 USD |
Sale | 1,780 | 265.7926 USD |
Sale | 1,936 | 265.5073 USD |
Sale | 1,995 | 265.3468 USD |
Sale | 2,502 | 265.5930 USD |
Sale | 2,550 | 265.7318 USD |
Sale | 2,811 | 265.9374 USD |
Sale | 5,164 | 265.4251 USD |
Sale | 17,645 | 265.7600 USD |
Sale | 23,817 | 265.9255 USD |
Sale | 24,905 | 265.7018 USD |
Sale | 80,159 | 265.8776 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | YES |
| Date of disclosure: | 18 May 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
| Product name | Written or | Number of | Exercise | Type | Expiry |
| purchased | relevant securities | price | date | ||
| to which the option | |||||
| or derivative | |||||
| relates | |||||
Put Options | Purchased | -100 | 220.0000 | American | Jul 16, 2021 |
Call Options | Purchased | 100 | 240.0000 | American | Jul 16, 2021 |
Call Options | Purchased | 6,000 | 220.0000 | American | Jul 16, 2021 |
Put Options | Purchased | -6,000 | 200.0000 | American | Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210518005598/en/
Copyright Business Wire 2021
Related Shares:
Barclays